(Q34605202)

English

Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B. (English)

1 reference

Europe PubMed Central

3 August 2017

chronic hepatitis

1 reference

based on heuristic

inferred from title

Keiichi Fujiwara

1

object named as

Keiichi Fujiwara

1 reference

Europe PubMed Central

3 August 2017

4

object named as

Tatsuo Kanda

1 reference

Europe PubMed Central

3 August 2017

2

object named as

Osamu Yokosuka

1 reference

Europe PubMed Central

3 August 2017

author name string

Hiroshige Kojima

3

1 reference

Europe PubMed Central

3 August 2017

Hiromitsu Saisho

5

1 reference

Europe PubMed Central

3 August 2017

Hiroyuki Hirasawa

6

1 reference

Europe PubMed Central

3 August 2017

Hiroshi Suzuki

7

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

3 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

3 August 2017

11

1 reference

Europe PubMed Central

3 August 2017

8

1 reference

Europe PubMed Central

3 August 2017

1109-1114

1 reference

Europe PubMed Central

3 August 2017

Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

7 July 2018

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

7 July 2018

Hepatitis B virus immunopathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

7 July 2018

DNA polymerase associated with human hepatitis B antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

7 July 2018

Hepatitis B virus DNA contains a glucocorticoid-responsive element

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

7 July 2018

Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

7 July 2018

Treatment of HBV reactivation after withdrawal of immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

7 July 2018

Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

7 July 2018

Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4250699

26 October 2018

Treatment of fibrosing cholestatic hepatitis with lamivudine

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I8.1109

21 January 2018

Corticosteroids in the treatment of acute hepatitis in coma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active Hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lamivudine is safe and effective in fulminant hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steroid therapy in severe viral hepatitis. A double-blind, randomized trial of methyl-prednisolone versus placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy and hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15754390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V11.I8.1109

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34605202&oldid=1962910845"